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Chlorophytum borivilianum Santapau & Fernandes (Liliaceae) is an ayurvedic Rasayana herb with immunostimulatingproperties.
The polysaccharide fraction (CBP) derived from hot water extraction of C. borivilianum (CB), comprising of ∼31% inulin-type
fructans and ∼25% acetylated mannans (of hot water-soluble extract), was evaluated for its eﬀect on natural killer (NK) cell
activity (in vitro). Human peripheral blood mononuclear cells (PBMCs), isolated from whole blood on a Ficoll-Hypaque density
gradient, were tested in the presence or absence of varying concentrations of each C. borivilianum fraction for modulation of
NK cell cytotoxic activity toward K562 cells. Preliminary cytotoxicity evaluation against P388 cells was performed to establish
non-cytotoxic concentrations of the diﬀerent fractions. Testing showed the observed signiﬁcant stimulation of NK cell activity
to be due to the CBP of C. borivilianum.F u r t h e r m o r e ,in vivo evaluation carried out on Wistar strain albino rats for humoral
response to sheep red blood cells (SRBCs) and immunoglobulin-level determination using enzyme-linked immunosorbent assay
(ELISA), exhibited an eﬀectiveness of C. borivilianum aqueous extract in improving immune function. Present results provide
useful information for understanding the role of CBP in modulating immune function.
1.Introduction
Chlorophytum borivilianum constitutes an important class of
ayurvedic herbs which are known as Rasayana, that is, herbs
with immunostimulatory and adaptogenic properties [1].
“Rasayana” therapy isa specialized measure in Ayurvedathat
deals with the proper modulation of the neuro-endocrino-
immunological system [2]. Rasayan therapy aims to boost
and nourish the body to balance the bodily functions and
counteracttheagingprocessbybringinghomeostasis, thatis,
a balance between the various bodily humors (viz. the Vata,
the Pittaand the Kapha)[ 3–5]. Evidencecollected onvarious
Rasayana herbs signiﬁes their utility as immunomodulators
with low toxicity [6, 7].
Chlorophytum borivilianum Sant F. (Fam. Liliaceae) is
widely cultivated throughout India, especially in the states
of Madhya Pradesh, Andhra Pradesh and Maharashtra,
and exported globally for its medicinal usage [8]. Major
phytochemical components reported from the roots of
C. borivilianum include steroidal saponins, fructans and
fructoligosaccharides (FOS), acetylated mannans, phenolic
compounds and proteins [9–12]. The plant is acclaimed
for various health beneﬁts, which include its ability to
ameliorate hyperlipidemia, diabetes-induced sexual dys-
function and prevent heat-induced testicular damage. The
p l a n ti sa l s oc o n s i d e r e dt ob eu s e f u la sa na n t i o x i d a n t
[13–16].
In our previous study, we reported the improvement
of in vivo immunomodulation by the ethanol extract of
C. borivilianum [17]. Extensive phytochemical evaluation
of the roots of C. borivilianum led to the quantiﬁcation
of nearly 60% w/w of polysaccharides in the hot water-
soluble material, which were found to be mainly fructans
and acetylated mannans [16]. Since these polysaccharides
have been cited for their immunomodulatory potential,
various fractions of C. borivilianum aqueous extract were
evaluated fortheir eﬀect on the modulation or enhancement
of human natural killer (NK) cell activity, hemagglutination
(HA) titer values against sheep red blood cells (SRBCs) and
immunoglobulin G (IgG) levels in rats.2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Fractionation of crude aqueous extract and various
fractions evaluated for biological activity.
2.Methods
2.1. Plant Material. Dried roots of C. borivilianum were
procured from Nandan Agro Farms, Hyderabad, India, and
identiﬁed at the Department of Pharmaceutical Sciences,
Dr. H.S. Gour Vishwavidyalaya, Sagar (India). A voucher
specimen of the same has been deposited in the depart-
mental herbarium (MTCB-1608). The powdered roots were
subjected to hot water extraction using the methodology
reported previously [15] and the procedure on the isolation
and fractionation of the aqueous extract of C. borivilianum
has been detailed in Figure 1. Cytotoxicity of the fractions
was evaluated on the P388 cell line. The aqueous extract of
the root powder (CBC), the polysaccharide (CBP) and non-
polysaccharide (CBR) fractions were used for evaluating the
eﬀectonm odula ti onofNKc ella cti vi tyin vitro,a n dH At i t e r
assay and IgG level in vivo.
2.2. Animal Group. A total of 72 Wistar strain albino rats
(either sex) in the weight range of 160–180g were fed a
standard pellet diet and water ad libitum. The animals were
housed at room temperature (24 ± 2◦C) on a normal day-
night cycle (6.00 a.m. to 6.00 p.m.). The guidelines given by
the Committee for the Purpose of Supervision and Control
of Experiments on Animals, India, were strictly followed.
SRBCs were procured from the Haﬀkine Biopharmaceutical,
Mumbai, India. All the other chemicals and reagents used
were of analytical grade.
2.3. Animal Group for HA Titer Value. Fourteen days prior
to experimentation, two sets of six groups, comprising
of six animals in each group, received experimental drug
administration as per the following schedule.
(i) Group I: Served as control and was administered
vehicle only.
(ii) Group II: 100mg of C. borivilianum aqueous extract
per kilogram of body weight (CBC).
(iii) Group III: 50mg of C. borivilianum polysaccharide
fraction per kilogram of body weight (CBP50).
(iv) Group IV: 100mg of C. borivilianum polysaccharide
fraction per kilogram of body weight (CBP100).
(v) Group V: 50mg of C. borivilianum non-polysaccha-
ride fraction per kilogram of body weight (CBR 50).
(vi) Group VI: 100mg of C. borivilianum non-polysac-
charide fraction per kilogram of body weight (CBR
100).
2.4. HA Titer Determination. On day 0, paralleling the above
mentioned treatment, animals were immunized by injecting
0.5mL of 5.0 × 109 SRBC/mL via the intraperitoneal route
(i.p.). On day 7 the animals were challenged by injecting
the same volume of SRBCs. Blood samples were collected
by retro-orbital puncture on day 14 for antibody titer.
Hemagglutination antibody titer was determined by using
the micro-titration technique described by Damre et al. [18].
For experimentation, 40μLo f0 . 1 %( w / v )b o v i n es e r u m
albumin (BSA) solution in normal saline was pipetted into
the wells of micro-titration plates. To this solution, 40μLo f
serum of either the treated or control animal was added,
which was later serially diluted 2-fold. Further 20μLo fa
0.1% suspension of SRBCs in BSA-saline was added to each
well; the plate was initially incubated at 37◦Cf o r6 0 m i n
followed by 60min at 4◦C .T h ev a l u eo ft h eh i g h e s ts e r u m
dilution causing visible hemagglutination was considered to
be the antibody titer.
2.5. IgG-Level Determination. For the determination of IgG
levels (on day 0) animals were immunized by injecting
0.2mL of 1% w/v BSA in phosphate-buﬀered saline (PBS)
solution. After immunization, each group of animals was
subjected to a drug-treatment schedule of 14 days as
described above. On day 7, blood samples were collected
and the IgG level of immunized animals was measured
using a simple indirect enzyme-linked immunosorbent assay
(ELISA)and recorded as primary antibody levels.On day 14,
animals were further challenged with 0.2mL of 1% w/v BSA.
On day 21, blood samples were collected by retro-orbital
puncture, subjected to an ELISA determination of IgG levels
and recorded as secondary antibody levels [19]. To perform
the ELISA, wells of the ELISA plates were coated with 100μL
of1%w/vBSAin PBSand incubatedat37◦Cf or1h.I nor der
to ensure the removal of unbound BSA, three washings were
doneusing PBS-0.05%Tween (PBS-T)solution.Serumsam-
ples were diluted 1000-fold in PBS and 25μLo ft h ed i l u t e d
serum samples were added in corresponding wells, followed
by 1h incubation. The unbound antibodies were removed
by washing thrice with PBS-T solution. A solution of 50μLEvidence-Based Complementary and Alternative Medicine 3
of rabbit anti-rat IgG-Horseradish peroxidase (HRP) was
addedtoallthewellsandincubatedfor60min. Allwellswere
washed 3 times to remove the unbound materials and 50μL
ofsubstratetetramethylbenzidine-hydrogenperoxide(TMB-
H2O2)w a sa d d e da n di n c u b a t e df o r5 m i n .T h ee n z y m e -
substrate reaction was terminated by the addition of 50μL
of 5N sulfuric acid (H2SO4). The absorbance was measured
at 450nm and the results calculated were recorded and
expressed as log10 values.
2.6. Cellular Cytotoxicity Evaluation. Mouse leukemic P388
cells were routinely cultured in a humidiﬁed 5% CO2 incu-
bator(Sanyo, Japan) in Dulbecco’sModiﬁed Eagle’s Medium
(DMEM) + 10% horse serum (HS), to which penicillin G
(500U/mL), streptomycin (5000μg/mL) and 3.5mg/mL of
D-glucose at 37◦C were added. Cell concentrations were
measured using an AcT Diﬀ analyzer (Beckman, Australia).
To maintain exponential growth, cells were seeded at 1 ×
105 cells/mL and passaged every 4-5 days. Chlorambucil and
curcumin were used as positive controls for the assay. The
commercially available ATPLite kit (Perkin Elmer, USA) was
used to assess cell viability. A ﬁnal cell concentration of
4000 cells/well was maintained using appropriate dilutions
in DMEM + 10% HS media.
Two-fold serial dilutions of chlorambucil and curcumin
were made starting at concentrations of 600 and 100μg/mL,
respectively. Solvent and media controls were also included
in the assay. The samples were assayed at various concentra-
tions of CBC, CBP and CBR starting at 10mg/mL. Testing
was performed in duplicate. For this, 50μL of sample was
a d d e dt oe a c hw e l la l o n gw i t h5 0μL of P388 cell suspension.
The cells and samples were incubated at 37◦Cf o r2 4hi na
humidiﬁed 5% CO2 incubator (Sanyo, Japan). Measurement
of cell proliferation (ATP) was performed as per ATPLite kit
protocol (Perkin Elmer, Netherlands) using the Micro Beta
1450 plate reader (Perkin Elmer, USA).
2.7. NK Cell Activity. Samples (CBC, CBP and CBR) were
prepared by dissolving the material at an initial concentra-
tion of 10mg/mL in de-ionized Milli Q water (Millipore,
UK) and appropriately diluted in water to obtain the ﬁnal
concentrations as required. The samples were vortexed and
sonicated for 10min to ensure complete solubility.
In vitro NK cell activity was assayed by ﬂow cytometry
using a Becton Dickinson FACS Calibur instrument. The
methodology reported by Standen et al. [20]w a su s e dw i t h
little modiﬁcation. In brief, peripheral blood mononuclear
cells (PBMCs) were prepared from fresh, whole, lithium-
heparinized blood using Ficoll-Hypaque (Amersham Bio-
sciences). Human PBMCs were suspended in advanced
Roswell Park Memorial Institute (RPMI)-1640 medium
(2% fetal BS; 1% l-glutamine; 2% penicillin/streptomycin)
and aliquots of cells were pre-incubated with each extract
dilution for 2h at 37◦Ci n5 %C O 2.T h eP B M C s( N K
cells/eﬀectors) were then incubated for 2h (37◦C, 5% CO2)
with target cells (K562; ATCC) pre-labeled with Vybrant
DiO cell labeling solution (Molecular Probes, Invitrogen, V-
22886), a green ﬂuorescent dye that allows diﬀerentiation of
target from eﬀector cells. The eﬀector:target cell ratio used
was 30:1. Propidium iodide (Molecular Probes, P-3566), a
red ﬂuorescent DNA dye, was added following incubation
to label target cells, which were rendered permeable by
NK cell activity. A target cell control (no eﬀectors) was
run for each sample to monitor spontaneous target cell
death. Protein-bound polysaccharide (PSK), which has been
validated for its selective activation of NK cells in a mouse
experimental tumor model, was used as a positive control
[21]. A solvent control (water) was also run and each
sample was tested in duplicate.The percentage of dead target
cells was determined by ﬂow cytometry using CellQuest
Pro software. The percentage of speciﬁc cytotoxicity was
determined by subtracting the percentage of dead cells in the
target control tube from the percentage of dead target cells in
each test sample.
2.8. Statistics. Statistical analysis and sample size was deter-
mined using Instat v 2.01. Conﬁdence was set at 95%. All the
groups were compared to control using one-way Analysis of
Variance (ANOVA) followed by Dunnet’s test. Signiﬁcance
was set at P<. 05.
3.Results
Eﬀectiveness of C. borivilianum on various aspects of the
immune system was clearly demonstrated in the present
study. CBC, CBP and CBR were evaluated for their eﬀect on
NK cell activity, humoral and cellular immune response.
3.1. Cytotoxicity Evaluation. As previously reported, CBC
was found to be non-toxic up to a dose of 2g per kilogram
of body weight [16]. In the present study, an evaluation of
the cytotoxicity and determination of IC50 was carried out
on the sensitive mouse leukemic P388 cell line. Curcumin
and chlorambucil were used as positive controls for the
determination of cytotoxicity. The results conﬁrmed the
non-toxic nature of the C. borivilianum extract under
investigation. CBC and CBP exhibited IC50 values of 1219.67
and 722.31μg/mL, respectively (Figure 2).
3.2. HA Titer Value. The values for HA titer in the case of
the vehicle-treated control group animals were established at
147.6 ± 11.9. Signiﬁcantly higher HA titer values of 169.2
± 6.1, 174.3 ± 3.1, and 168.6 ± 2.6 were observed for CBC
and CBP at 100μg/mL and CBP at 50μg/mL, respectively.
However, CBR only showed mild increases in HA titer of ∼
8.6% and 8.1% at 100 and 50μg/mL, respectively. The results
for HA titer values observed are detailed in Figure 3.
3.3. IgG Level. ELISA-based measurements were used for
the secondary antibody responses in immunized animals.
Administration of CBC resulted in a signiﬁcant increase
(P<. 01) in IgG level (1.93 ± 0.02), followed by CBP100
(1.85 ± 0.01) and CBP50 (1.81 ± 0.04). CBR50 and CBR100
gave similar IgG levels of 1.82 ± 0.12 and 1.82 ± 0.11 units,
respectively. In the case of control animals (vehicleonly), the
v a l u ew a sf o u n dt ob e1 . 7 4± 0.013 units (Figure 4).4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: IC50 values of C. borivilianum aqueous extract and
fractions against P388 cells.
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Figure3:Eﬀect ofC. borivilianum aqueousextract andfractionson
HA titer values in Wistar rats.
3.4. NK Cell Activity. In comparison to the control, a
signiﬁcantly higher eﬀect of CBP (P<. 01) in augmenting
the NK cell activity was observed. Although CBC stimulated
NK cells signiﬁcantly (P<. 05), most of the eﬀect appeared
to be contributed by CBP alone. Therefore, polysaccharides
of C. borivilianum appeared to be solely responsible for
NK cell augmentation. In the case of CBR, no eﬀect was
observable, and the result obtained was equivalent to that
of the solvent control group. At a ﬁnal concentration of
5μg/mL the CBP fraction resulted in an ∼2-fold increase
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Figure 4: Eﬀect of treatment with C. borivilianum aqueous extract
and fractions on Immunoglobulin (IgG) levels in Wistar rats after
28 days.
in NK cell activity (98 ± 2.5%), whereas at 25μg/mL, the
% increment was 58.4 ± 0.3%. This indicates that the
isolated polysaccharide fraction is more eﬀective at the lower
concentration tested. In the case of CBC, some semblance
of a dose-dependent eﬀect was observed, wherein a 72.9
± 4.4% and 86.6 ± 0.7% increase in NK cell activity was
observed with CBC at 5 and 50μg/mL, respectively. There
was no enhancement in relative NK cell activity for CBR at 5
and 25μg/mL. The diﬀerences in relative activity compared
to control groups have been shown in Figure 5.
4.Discussion
Ayurvedic Rasayan herbs have been acclaimed for their
ability to enhance the functionality of the immune system.
Appropriate modulation of biological homeostasis in order
to boost the ability to ﬁght infection, counteract diseases,
prevent cancer, and so forth, is the primary focus of Rasayan
therapy [22]. C. borivilianum is renowned for its ability to
boost immune function [17]. Interactions among immune
cells and those of immune cells with the other tissues
in the body are highly diversiﬁed and mostly unexplored.
The ability to counteract infections or to ﬁght against
cancer mainly involves a three-tiered functionality: humoral
immunity, cellular immunity and the regulators of immune
system, such as cytokines [23]. Previously we had reported
the eﬀectiveness of ethanol fraction of the C. borivilianum
extract on improving non-speciﬁc immunity [17]; in the
present study we have been able to determine the possible
role of CBP on immune modulation.
A burgeoning area of research is the development or dis-
covery of immunomodulatory agentsthat are free from toxicEvidence-Based Complementary and Alternative Medicine 5
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in vitro NK cell activity against K562 cells.
sideeﬀectsandcanbeusedforalongduration,thusresulting
in continuous immuno-activation [24]. Previous research
carried out on Rasayan herbs has validated that they activate
immune functionality without causing an imbalance in
overall physiology; this aspect has been excellently reviewed
by Vayalil et al. [6]. Similar to many immunomodulatory
substances, Rasayanas are not directly cytotoxic to tumor
cells; rather they produce signiﬁcant inhibitory eﬀect on
ascites tumor development and solid tumor growth in mice
during the treatment period [25]. Rasayanas have been
previously considered to act via in vivo augmentation of NK
cellactivityaswell asantibody-dependentcellulartoxicity.In
thepresentstudy,anenhancedNKcellactivity ofCBPaswell
as CBC against K562 myeloid leukemic cells clearly validates
the immunopotentiating ability of fructans and mannans
isolated from C. borivilianum [26].
Augmentation of NK cell activity is considered an
important parameter for improved immunological function.
NK cells are a subset of lymphocytes that are important in
the body’s defense against viral infections and malignancy,
participating in innate immunity and early defenses [26, 27].
They are deﬁned functionally by their ability to mediate
spontaneous cytotoxicity, lysing a broad range of target
cells without prior sensitization and without restriction
by major histocompatibility complex (MHC) antigens [28,
29]. Impaired NK cell activity is associated with increased
sensitivity to infection [30]. NK cells are a major force in
counteracting, and ﬁghting, against cancer.
As previously mentioned, Rasayan herbs are generally
regarded as non-toxic even at high doses. A toxicity assay
using the ATPLite kit clearly suggested that the extracts and
fractions from C. borivilianum were non-cytotoxic against
P388 cells, a sensitive mouse cell line. In our previous studies
on the plant, in vivo toxicity was evaluated and the extracts
were found to be non-toxic evenat a dose of2g per kilogram
ofbody weight. Lackofcytotoxicityisan important attribute
of Rasayan drugs and this was validated in the case of C.
borivilianum as well.
The crude C. borivilianum e x t r a c ta sw e l la st h e
polysaccharide fraction were able to enhance the antibody
titer, while the non-polysaccharide fraction was eﬀective
in enhancing a cell-mediated response. Augmentation of
the humoral response was evidenced by increased antibody
production in response to SRBC challenge in the post-
immunization drug treatment. The enhanced responsiveness
is indicative of up-regulation of macrophages, dendritic cells
and B-lymphocyte subsets involved in antibody synthesis.
T-lymphocyte activation is also considered an important
attribute of polysaccharides, which is directly correlated
with immuno-stimulation. This cascade of functionalities
provides evidence for an enhancement of humoral as
well cellular immune responsiveness [31]. A diagrammatic
representation of the overall assessment of C. borivilianum is
shown in Figure 6.
Rasayana herbs or their extracts have been found to
be eﬀective in enhancing the production of cytokines such
as interleukin (IL)-2, interferon (IFN)-γ and granulocyte
macrophage colony-stimulating factor (GM-CSF) in albino
rats [32]. Further studies in this direction are warranted on
the extracts/fractions of C. borivilianum.
In recent years, there have been reports on the presence
of speciﬁc polysaccharides, such as fructans, acetylated man-
nans, xylans and glucans, in Rasayan herbs. These polysac-
charides from medicinal plantsexhibit biologicalactivities of
importance for improving human health. Perhaps the most
important activity would be on the immune system, which
may lead to the production of nutritional supplements in
cancer treatment [33, 34]. As validated in the case of C.
borivilianum, the use of these polysaccharides will stimulate
the immune system and may also contribute to lowering the
dose ofexisting immune therapeutics. These polysaccharides
c a nb eu s e di nr e l a t i v e l yl a r g ed o s e sw i t hn os i d ee ﬀects;
accompanying these facets are the juxtaposed benevolent
attributes such as their eﬀects on diﬀerent viral infections,
diabetes and aging-related problems [35, 36].
The present study provides further insight into the
potential immunomodulator herb C. borivilianum and pro-
vides some in vitro evidence. It can be further inferred
from this study that the polysaccharide fraction is the
most eﬀective in augmenting the NK cell activity as well
as humoral immunity. The remaining fraction of extract,
which is rich in phenolics and saponins [13], was useful
in improving the HA titer, but had no eﬀect on NK cell
activity. Thus, it can be concluded that the C. borivilianum
extract acts via a cascade of mechanisms, modulating the
immune system to improve and restore a healthy state. The
polysaccharides from C. borivilianum could be considered
for cancer treatment via post-chemotherapy revival of the
immune system. This study further validates and provides6 Evidence-Based Complementary and Alternative Medicine
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molecular evidence for the potential beneﬁts of Rasayan
herbs of the ayurvedic system of medicine.
Funding
MT would like to thank the Department of Education,
Employment and Workplace Relations (DEEWR) for the
funding in the form of Endeavour Postdoctoral Research
Fellowship.
Acknowledgments
MT would like to acknowledge Southern Cross University
for hosting the research. The authors would also like to
express sincere thanks to Mr. Aaron Pollack, Centre for Phy-
tochemistry and Pharmacology, Southern Cross University,
for acting as blood donor.
References
[1] M. Thakur, N. S. Chauhan, S. Bhargava, and V. K. Dixit, “A
comparative study on aphrodisiac activity of some ayurvedic
herbs in male albino rats,” Archives of Sexual Behavior,v o l .3 8 ,
no. 6, pp. 1009–1015, 2009.
[2] B. Patwardhan, D. Warude, P. Pushpangadan, and N. Bhatt,
“Ayurveda and traditional Chinese medicine: a comparative
overview,” Evidence-Based Complementary and Alternative
Medicine, vol. 2, no. 4, pp. 465–473, 2005.
[3] S. Mahdihassan, “The rational interpretation of the Indian
doctrine of humorology,” American Journal of Chinese
Medicine, vol. 10, no. 1–4, pp. 40–43, 1982.
[4] H. Joshi and M. Parle, “Brahmi rasayana improves learning
and memory in mice,” Evidence-Based Complementary and
Alternative Medicine, vol. 3, no. 1, pp. 79–85, 2006.
[5] V. M. Shinde, K. Dhalwal, K. R. Mahadik, K. S. Joshi, and B.
K. Patwardhan, “RAPD analysis for determination of compo-
nentsinherbalmedicine,”Evidence-BasedComplementaryand
Alternative Medicine, vol. 4, supplement 1, pp. 21–23, 2007.
[6] P. K. Vayalil, G. Kuttan, and R. Kuttan, “Rasayanas: evidence
for the concept of prevention of diseases,” American Journal of
Chinese Medicine, vol. 30, no. 1, pp. 155–171, 2002.
[7] A. Chopra, “Ayurvedic medicine and arthritis,” Rheumatic
Disease Clinics of North America, vol. 26, pp. 133–144, 2000.
[8] M. Thakur and V. K. Dixit, “Eﬀect of Chlorophytum borivil-
ianum on androgenic & sexual behavior of male rats,” Indian
Drugs, vol. 43, pp. 300–306, 2006.
[9] N. Kaushik, “Saponins of Chlorophytum species,” Phytochem-
istry Reviews, vol. 4, no. 2-3, pp. 191–196, 2005.
[10] S. Narasimhan, R. Govindarajan, V. Madhavan et al., “Action
of (2→1)fructo-oligopolysaccharide fraction of Chlorophy-
tum borivilianum against streptozotocin-induced oxidative
stress,” Planta Medica, vol. 72, no. 15, pp. 1421–1424, 2006.
[ 1 1 ]M .T h a k u r ,R .L o e p p e r t ,W .P r a z n i k ,a n dV .K .D i x i t ,“ E ﬀect
of some ayurvedic vajikarana rasayana herbs on heat induced
testicular damage in male rats,” International Journal of
Computational Medicine, vol. 5, pp. 1–14, 2008.
[12] D. Acharya, A.-C. Mitaine-Oﬀe r ,N .K a u s h i ke ta l . ,“ C y t o t o x i c
spirostane-type saponins from the roots of Chlorophytum
borivilianum,” Journal of Natural Products,v o l .7 2 ,n o .1 ,p p .
177–181, 2009.
[13] R. Govindarajan, S. Narasimhan, V. Madhavan et al., “In
vitro antioxidant activity of ethanolic extract of Chlorophytum
borivilianum,” Natural Product Sciences, vol. 11, pp. 165–169,
2005.
[ 1 4 ]N .P .V i s a v a d i y aa n dA .V .R .L .N a r a s i m h a c h a r y a ,“ A m e -
liorative eﬀect of Chlorophytum borivilianum root on lipid
metabolism in hyperlipaemic rats,” Clinical and Experimental
Pharmacology andPhysiology,vol.34,no.3,pp.244–249,2007.
[15] M. Thakur and V. K. Dixit, “Ameliorative eﬀect of fructo-
oligosaccharide rich extract of Orchis latifolia linn. on sexual
dysfunction in hyperglycemic male rats,” Sexuality and Dis-
ability, vol. 26, no. 1, pp. 37–46, 2008.
[16] M. Thakur, S. Bhargava, V. Sharma, R. Loeppert, W. Praznik,
a n dV .K .D i x i t ,“ E ﬀect of Chlorophytum borivilianum Sant. &
F. on sexual dysfunction in hyperglycemic male rats,” Chinese
Journal of Internal Medicine, vol. 15, pp. 448–453, 2009.
[17] M.Thakur ,S.Bhargava,andV .K.Dixit,“I mmunomodulat ory
activity ofChlorophytum borivilianum Sant.F,”Evidence-Based
Complementary and Alternative Medicine,v o l .4 ,n o .4 ,p p .
419–423, 2007.
[18] A. S. Damre, A. B. Gokhale, A. S. Phadke, K. R. Kulkarni, and
M. N. Saraf, “Studies on the immunomodulatory activity of
ﬂavonoidal fraction of Tephrosia purpurea,” Fitoterapia,v o l .
74, no. 3, pp. 257–261, 2003.Evidence-Based Complementary and Alternative Medicine 7
[19] J. Katz, C. C. Harmon, G. P. Buckner, G. J. Richardson,
M. W. Russell, and S. M. Michalek, “Protective salivary
immunoglobulin A responses against Streptococcus mutans
infection afterintranasalimmunizationwithSm u t a n santigen
I/II coupled to the B subunit of cholera toxin,” Infection and
Immunity, vol. 61, pp. 1964–1971, 1993.
[20] M. D. Standen, P. A. Connellan, and D. Leach, “Natural
killer cell activity and lymphocyte activation: investigating the
eﬀects of a selection of essential oils and components in vitro,”
International Journal of Aromatherapy, vol. 16, pp. 133–139,
2006.
[21] S. Pedrinaci, I. Algarra, and F. Garrido, “Protein-bound
polysaccharide (PSK) induces cytotoxic activity in the NKL
humannaturalkiller cell line,” International Journal of Clinical
and Laboratory Research, vol. 29, no. 4, pp. 135–140, 1999.
[22] M. Ali, “Rasayana therapy in classical literature of Ayurveda:
ar e v i e w , ”Bulletin of the Indian Institute of History of Medicine
(Hyderabad), vol. 28, no. 2, pp. 95–110, 1998.
[23] K. S. Kubena and D. N. McMurray, “Nutrition and the
immune system: a review of nutrient-nutrient interactions,”
Journal of the American Dietetic Association,vol.96,no.11, pp.
1156–1164, 1996.
[24] P.-F. Su, V. Staniforth, C.-J. Li et al., “Immunomodulatory
eﬀects ofphytocompounds characterized byinvivo transgenic
human GM-CSF promoter activity in skin tissues,” Journal of
Biomedical Science, vol. 15, no. 6, pp. 813–822, 2008.
[25] P. K. Vayalil, G. Kuttan, andR. Kuttan, “Eﬀect ofRasayanason
normal and tumor bearing animals,” Journal of Experimental
and Clinical Cancer Research, vol. 13, pp. 67–70, 1994.
[26] B. K. Pedersen, “Natural killer cells in relation to disease and
treatment,” Allergy, vol. 40, no. 8, pp. 547–557, 1985.
[27] J.Brittenden,S.D.Heys,J.Ross,andO.Eremin,“Naturalkiller
cells and cancer,” Cancer, vol. 77, no. 7, pp. 1226–1243, 1996.
[28] R. B. Herberman, “Natural killer (NK) cells and their possible
roles in resistance against disease,” Clinical Immunology
Reviews, vol. 1, no. 1, pp. 1–65, 1981.
[29] W. Walker, M. Aste-Amezaga, R. A. Kastelein, G. Trinchieri,
a n dC .A .H u n t e r ,“ I L - 1 8a n dC D 2 8u s ed i s t i n c tm o l e c u l a r
mechanisms to enhance NK cell production of IL-12-induced
IFN-γ,” Journal of Immunology, vol. 162, no. 10, pp. 5894–
5901, 1999.
[ 3 0 ]B .L .A n d e r s e n ,W .B .F a r r a r ,D .G o l d e n - K r e u t ze ta l . ,“ S t r e s s
and immune responses after surgical treatment for regional
breast cancer,” Journal of the National Cancer Institute,v o l .9 0 ,
no. 1, pp. 30–36, 1998.
[31] S. V. Fulzele, P. M. Bhurchandi, V. M. Kanoje, S. B. Joshi,
a n dA .K .D o r l e ,“ I m m u n o s t i m u l a n ta c t i v i t yo fA s h t a m a n g a l
ghrita in rats,” Indian Journal of Pharmacology, vol. 34, no. 3,
pp. 194–197, 2002.
[32] P. S. Rekha, G. Kuttan, and R. Kuttan, “Immunopotentiating
activity ofBrahmaRasayana,”Amala ResearchBulletin,vol.18,
pp. 85–90, 1998.
[33] B. S. Paulsen, “Biologically active polysaccharides as possible
lead compounds,” Phytochemistry Reviews,v o l .1 ,n o .3 ,p p .
379–387, 2002.
[34] B.S.Paulsen,“Plantpolysaccharideswithimmunostimulatory
activities,” Current Organic Chemistry, vol. 5, no. 9, pp. 939–
950, 2001.
[35] J.W .Hsu,H.C.H uang,S.T .Chen,C.H.W ong,andH.F .Juan,
“Ganoderma lucidum polysaccharides induce macrophagelike
diﬀerentiationinhumanleukemiaTHP-1cells viacaspaseand
p53 activation,” Evidence-Based Complementary and Alterna-
tive Medicine. In press.
[36] Y. Han, S.-J. Son, M. Akhalaia et al., “Modulation of
radiation-induceddisturbancesofantioxidantdefensesystems
by ginsan,” Evidence-Based Complementary and Alternative
Medicine, vol. 2, no. 4, pp. 529–536, 2005.